MXPA05006765A - Procedimiento de deteccion de prp utilizando un antibiotico de aminoglicosidos. - Google Patents

Procedimiento de deteccion de prp utilizando un antibiotico de aminoglicosidos.

Info

Publication number
MXPA05006765A
MXPA05006765A MXPA05006765A MXPA05006765A MXPA05006765A MX PA05006765 A MXPA05006765 A MX PA05006765A MX PA05006765 A MXPA05006765 A MX PA05006765A MX PA05006765 A MXPA05006765 A MX PA05006765A MX PA05006765 A MXPA05006765 A MX PA05006765A
Authority
MX
Mexico
Prior art keywords
prpsc
detection method
aminoglycoside antibiotic
antibiotic
relates
Prior art date
Application number
MXPA05006765A
Other languages
English (en)
Inventor
Ambroise Martin
Original Assignee
Afssa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Afssa filed Critical Afssa
Publication of MXPA05006765A publication Critical patent/MXPA05006765A/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2814Dementia; Cognitive disorders
    • G01N2800/2828Prion diseases
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/104998Glucose, ketone, nitrate standard or control

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La presente invencion se refiere a un procedimiento de concentracion por precipitacion de PrPSC a utilizar cuando la deteccion o el diagnostico de PrPsc, caracterizado porque se pone en presencia un tejido o un fluido biologico extraido u obtenido de un organismo animal o humano con un antibiotico de la familia de aminoglicosidos, de preferencia la estreptomicina o uno de sus derivados. La presente invencion se refiere igualmente a la utilizacion de tal antibiotico para la eliminacion de PrPSC de un tejido o de un fluido biologico. En fin, la invencion se refiere a un equipo de diagnostico de patologias relacionadas con la presencia de PrPSC.
MXPA05006765A 2002-12-20 2003-12-19 Procedimiento de deteccion de prp utilizando un antibiotico de aminoglicosidos. MXPA05006765A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0216382A FR2849204B1 (fr) 2002-12-20 2002-12-20 Procede de detection de la prpsc utilisant un antibiotique d de la famille des aminoglycosides pour l'elimination et la detection de la prpsc dans des echantillons biologiques
PCT/FR2003/003856 WO2004059321A1 (fr) 2002-12-20 2003-12-19 Procede de detection de la prp utilisant un antibiotique des aminoglycosides

Publications (1)

Publication Number Publication Date
MXPA05006765A true MXPA05006765A (es) 2006-02-17

Family

ID=32406304

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05006765A MXPA05006765A (es) 2002-12-20 2003-12-19 Procedimiento de deteccion de prp utilizando un antibiotico de aminoglicosidos.

Country Status (12)

Country Link
US (1) US7695918B2 (es)
EP (1) EP1573336B1 (es)
JP (1) JP4471844B2 (es)
CN (1) CN1729396A (es)
AT (1) ATE423321T1 (es)
AU (1) AU2003299389A1 (es)
BR (1) BR0317224A (es)
DE (1) DE60326269D1 (es)
ES (1) ES2322704T3 (es)
FR (1) FR2849204B1 (es)
MX (1) MXPA05006765A (es)
WO (1) WO2004059321A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2865280B1 (fr) * 2004-01-20 2007-01-12 Biomerieux Sa Procede de detection de la prp utilisant une molecule ayant au moins une charge positive et/ou au moins une liaison osidique et un ligand autre qu'un ligand proteique
FR2888937B1 (fr) * 2005-07-21 2012-10-26 Biomerieux Sa Procede de detection des fcpa utilisant un agent d'agregation des fcpa et un agent de capture des agregats formes
US7325983B1 (en) * 2006-08-25 2008-02-05 Emcore Corporation 10GBASE-LX4 optical transceiver in XFP package
US10010029B2 (en) * 2011-11-21 2018-07-03 Innovation Hammer, Llc Methods and systems for growing plants using silicate-based substrates, cultivation of enhanced photosynthetic productivity and photosafening by utilization of exogenous glycopyranosides for endogenous glycopyranosyl-protein derivatives, and formulations, processes and systems for the same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993544A (en) * 1975-01-20 1976-11-23 Massachusetts Institute Of Technology Derivatives of streptomycin and method of producing streptomycin derivatives by mutational biosynthesis
US6322802B1 (en) * 1999-06-01 2001-11-27 The Regents Of The University Of California Method of sterilizing
EP0861900A1 (en) * 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunological detection of prions
US6221614B1 (en) * 1997-02-21 2001-04-24 The Regents Of The University Of California Removal of prions from blood, plasma and other liquids
AU7365298A (en) 1997-05-02 1998-11-27 Integrated Research Technology, Llc Betaines as adjudvants to susceptibility testing and antimicrobial thera py
AU5241100A (en) * 1999-09-28 2001-04-30 Universitat Zurich Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis
ES2247085T3 (es) 2000-02-01 2006-03-01 Tiax, Llc Sistema de descontaminacion quimica y biologica.
IL141950A0 (en) * 2000-10-22 2002-03-10 Hadasit Med Res Service Diagnosis of prion diseases
DE10119713A1 (de) * 2001-04-21 2002-10-24 Prionics Ag Zuerich Verfahren zur Untersuchung von Prion-Protein enthaltenden Proben auf das eventuelle Vorliegen der PrPSc-Form
FR2865280B1 (fr) * 2004-01-20 2007-01-12 Biomerieux Sa Procede de detection de la prp utilisant une molecule ayant au moins une charge positive et/ou au moins une liaison osidique et un ligand autre qu'un ligand proteique
US20150041230A1 (en) 2013-08-12 2015-02-12 GKart Inc. Amusement vehicle, amusement environment for a vehicle and method of using the same

Also Published As

Publication number Publication date
ES2322704T3 (es) 2009-06-25
ATE423321T1 (de) 2009-03-15
US20060014215A1 (en) 2006-01-19
EP1573336A1 (fr) 2005-09-14
AU2003299389A1 (en) 2004-07-22
WO2004059321A8 (fr) 2005-06-30
AU2003299389A8 (en) 2004-07-22
JP2006510913A (ja) 2006-03-30
FR2849204A1 (fr) 2004-06-25
US7695918B2 (en) 2010-04-13
CN1729396A (zh) 2006-02-01
EP1573336B1 (fr) 2009-02-18
WO2004059321A1 (fr) 2004-07-15
DE60326269D1 (de) 2009-04-02
FR2849204B1 (fr) 2005-02-11
BR0317224A (pt) 2005-11-01
JP4471844B2 (ja) 2010-06-02

Similar Documents

Publication Publication Date Title
GB0203446D0 (en) Detection and/or monitoring of synuclein-related diseases
ATE461449T1 (de) Verfahren zum nachweis von medizinisch relevanten zuständen in gelösten lbc-proben
HUP0301020A2 (hu) Konformációs betegségek korai diagnosztikája
WO2007086986A3 (en) Novel application of biosensors for diagnosis and treatment of disease
MX2009003562A (es) Ensayo elisa para la deteccion de vegf.
AU2002902A (en) Method for differentiating irritable bowel syndrome from inflammatory bowel disease (ibd) and for monitoring persons with ibd using total endogenous lactoferrinas a marker
WO2006063093A3 (en) Methods for diagnosis and treatment of crohn's disease
WO2009132058A3 (en) Levels of bcma protein expression on b cells and use in diagnostic methods
DE60336452D1 (de) Fgfr agoniste
DE602004028731D1 (de) Zusammensetzungen und verfahren zur in vivo abbildung von loeslichen beta-amyloid
TW200744643A (en) Optical imaging of rheumatoid arthritis
TW200617174A (en) Method of diagnosing lawsonia intracellularis
ATE406579T1 (de) Verfahren zur diagnose von tumoren
MXPA05006765A (es) Procedimiento de deteccion de prp utilizando un antibiotico de aminoglicosidos.
MX2023006598A (es) Biomarcadores agonistas del trem2 y métodos para usarlos.
WO2006066917A3 (en) Use of asc as a marker for colorectal cancer
Godkhindi et al. The histopathological study of various gastro-duodenal lesions and their association with Helicobacter pylori infection
BRPI0408067A (pt) disgnóstico de autismo
RU2007135360A (ru) Способ измерения поглощенной дозы ионизирующего излучения
WO2004093662A3 (en) Method for detecting prognosis of cancer
DE502004012230D1 (de) Verfahren zur diagnose von erkrankungen unter bestimmung von apolipoprotein c-i
BR0209681A (pt) Método e kit para o diagnóstico in vivo ou para o monitoramento de uma doença que envolve uma reação inflamatória dentro de um paciente
DE602004022995D1 (de) Verfahren zur diagnose der immunität wiederkehrendren zur behandlung und überwachung
MX2022004017A (es) Deteccion de analitos por medio de interruptores de proteinas.
ATE420210T1 (de) Diagnose des brustkrebsrisikos

Legal Events

Date Code Title Description
FG Grant or registration